Innoveren Scientific Inc. (IVRN)
OTCMKTS: IVRN · Delayed Price · USD
0.0040
+0.0004 (11.11%)
Jul 26, 2024, 1:40 PM EDT - Market closed

Innoveren Scientific Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Net Income
-3.26-10.3-4.8-6.46-29.81-4.39
Depreciation & Amortization
0.010.010.020.080.830.1
Other Amortization
---1.40.15-
Loss (Gain) From Sale of Assets
-0.010.090--
Asset Writedown & Restructuring Costs
0.792.040.14-15.510.61
Stock-Based Compensation
0.150.591.180.041.88-
Provision & Write-off of Bad Debts
0.030.070.010.010.09-
Other Operating Activities
0.355.21-0.7-2.13-0.85-
Change in Accounts Receivable
-0.01-0.05-0.030.020.050.06
Change in Accounts Payable
0.420.36-0.42-0.480.12-0.1
Change in Unearned Revenue
--0.41-0.22-0.410.72-0.31
Change in Other Net Operating Assets
0.60.57-0.090.69-0.990.5
Operating Cash Flow
-0.92-1.91-4.81-7.26-12.29-3.54
Capital Expenditures
---0.01-0-0.02-0.01
Cash Acquisitions
-0---0.37-
Sale (Purchase) of Intangibles
------0.01
Investment in Securities
0.87-----
Investing Cash Flow
0.870-0.01-0-0.39-0.02
Short-Term Debt Issued
-0.533.33-1.640.94
Long-Term Debt Issued
---4.652.614.31
Total Debt Issued
0.650.533.334.654.255.24
Short-Term Debt Repaid
------1.86
Long-Term Debt Repaid
--0.12-0.05-0.01-0.37-
Total Debt Repaid
-0.13-0.12-0.05-0.01-0.37-1.86
Net Debt Issued (Repaid)
0.530.413.274.643.883.39
Issuance of Common Stock
0.031.43--4.34-
Dividends Paid
-----0.01-
Other Financing Activities
--0.01--2.4-
Financing Cash Flow
0.561.823.277.4814.043.39
Net Cash Flow
0.51-0.1-1.550.221.35-0.18
Free Cash Flow
-0.92-1.91-4.82-7.26-12.31-3.56
Free Cash Flow Margin
--422.03%-298.95%-337.57%-147.50%-45.11%
Free Cash Flow Per Share
-1.55-6.51-33.06-65.12-127.76-105.64
Cash Interest Paid
0.080.010.010.030.20.03
Levered Free Cash Flow
0.960.67-2.86-4.22-5.28-
Unlevered Free Cash Flow
1.240.9-2.75-4.7-5.25-
Change in Net Working Capital
-2.38-2.210.70.38-0.41-
Source: S&P Capital IQ. Standard template.